Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Latest reported BOLT revenue for 2026-06-30 was $31.0K. Net income was -$15.0M. Revenue was up 19.2% from 2026-03-31 to 2026-06-30. BOLT currently screens at market cap $11.3M.
Use this BOLT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BOLT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BOLT SEC filings page. Lician reads the product cache first so this HTML stays unique to Bolt Biotherapeutics even when a live quote feed is slow.
Latest cached year on this hub. Full BOLT income, balance, and cash tables.